000 01372 a2200385 4500
005 20250517103417.0
264 0 _c20170216
008 201702s 0 0 eng d
022 _a2374-2445
024 7 _a10.1001/jamaoncol.2016.1897
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpring, Laura M
245 0 0 _aNeoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis.
_h[electronic resource]
260 _bJAMA oncology
_cNov 2016
300 _a1477-1486 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review
650 0 4 _aAntineoplastic Agents, Hormonal
_xpharmacology
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeoadjuvant Therapy
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aReceptors, Estrogen
_xmetabolism
650 0 4 _aTreatment Outcome
700 1 _aGupta, Arjun
700 1 _aReynolds, Kerry L
700 1 _aGadd, Michele A
700 1 _aEllisen, Leif W
700 1 _aIsakoff, Steven J
700 1 _aMoy, Beverly
700 1 _aBardia, Aditya
773 0 _tJAMA oncology
_gvol. 2
_gno. 11
_gp. 1477-1486
856 4 0 _uhttps://doi.org/10.1001/jamaoncol.2016.1897
_zAvailable from publisher's website
999 _c26180629
_d26180629